These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 18272905)
21. CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population. Ronaghi M; Vallian S; Etemadifar M Psychiatry Res; 2009 Dec; 170(2-3):271-2. PubMed ID: 19896210 [TBL] [Abstract][Full Text] [Related]
26. Haplotype 4 of the multiple sclerosis-associated interleukin-7 receptor alpha gene influences the frequency of recent thymic emigrants. Broux B; Hellings N; Venken K; Rummens JL; Hensen K; Van Wijmeersch B; Stinissen P Genes Immun; 2010 Jun; 11(4):326-33. PubMed ID: 20072142 [TBL] [Abstract][Full Text] [Related]
27. Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients. Akkad DA; Hoffjan S; Petrasch-Parwez E; Beygo J; Gold R; Epplen JT J Autoimmun; 2009 Mar; 32(2):110-5. PubMed ID: 19231135 [TBL] [Abstract][Full Text] [Related]
28. The genetics of multiple sclerosis and its experimental models. Olsson T; Hillert J Curr Opin Neurol; 2008 Jun; 21(3):255-60. PubMed ID: 18451707 [TBL] [Abstract][Full Text] [Related]
29. CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population. Wray BN; Stankovich J; Whittock L; Dwyer T; Ponsonby AL; van der Mei IA; Taylor B; Dickinson J; Foote S; McMorran BJ J Neuroimmunol; 2008 May; 196(1-2):139-42. PubMed ID: 18378005 [TBL] [Abstract][Full Text] [Related]
30. IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response. Leyva L; Fernández O; Fedetz M; Blanco E; Fernández VE; Oliver B; León A; Pinto-Medel MJ; Mayorga C; Guerrero M; Luque G; Alcina A; Matesanz F J Neuroimmunol; 2005 Jun; 163(1-2):165-71. PubMed ID: 15885318 [TBL] [Abstract][Full Text] [Related]
31. IL7RA polymorphisms and chronic inflammatory arthropathies. O'Doherty C; Alloza I; Rooney M; Vandenbroeck K Tissue Antigens; 2009 Nov; 74(5):429-31. PubMed ID: 19744146 [TBL] [Abstract][Full Text] [Related]
32. The interleukin 23 receptor gene in multiple sclerosis: a case-control study. Roos IM; Kockum I; Hillert J J Neuroimmunol; 2008 Feb; 194(1-2):173-80. PubMed ID: 18164077 [TBL] [Abstract][Full Text] [Related]
33. Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian families. Ramagopalan SV; Morrison KM; Para A; Handel A; Disanto G; Handunnetthi L; Orton SM; Sadovnick AD; Ebers GC J Neuroimmunol; 2009 Jul; 212(1-2):142-4. PubMed ID: 19428123 [TBL] [Abstract][Full Text] [Related]
34. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis. Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430 [TBL] [Abstract][Full Text] [Related]
35. CASP-9: A susceptibility locus for multiple sclerosis in Italy. Andreoli V; Trecroci F; La Russa A; Valentino P; Condino F; Latorre V; Nisticò R; Pirritano D; Del Giudice F; Canino M; Cittadella R; Quattrone A J Neuroimmunol; 2009 May; 210(1-2):100-3. PubMed ID: 19359048 [TBL] [Abstract][Full Text] [Related]
40. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population. Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]